Repligen | RGEN - Денежные средства и эквиваленты





Денежные средства и эквиваленты Изменить Дата
Agilent USD 1.76B 49M 2026-06
Align Technology USD 1.1B 42.76M 2026-06
Bio Techne USD 264.71M 54.89M 2026-06
BioMarin Pharmaceutical USD 874M 1.35B 2026-06
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Bruker USD 184.9M 51.5M 2026-06
Charles River Laboratories USD 192.02M 195K 2026-06
Danaher USD 4.35B 1.35B 2026-06
Dentsply International USD 239M 49M 2026-06
General Electric Aerospace USD 9.35B 1.64B 2026-06
Henry Schein USD 157M 19M 2026-06
Illumina USD 1.09B 329M 2026-03
IQVIA Holdings USD 1.91B 38M 2026-06
Mettler Toledo International USD 51.38M 9.19M 2026-06
Myriad Genetics USD 115.2M 9.2M 2026-06
OraSure Technologies USD 160.58M 16.38M 2026-06
Pacific Biosciences Of California USD 61M 4.73M 2026-06
Pfizer USD 976M 727M 2026-06
Repligen USD 606.78M 24.13M 2026-06
Revvity USD 1.02B 162.62M 2026-06
Standard Biotools USD 265.77M 147.56M 2026-03
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Waters USD 539M 77M 2026-06
West Pharmaceutical Services USD 435.8M 85.6M 2026-06